Male breast cancer and 5&#945;-reductase inhibitors finasteride and dutasteride.

Bird, Steven T; Brophy, James M; Hartzema, Abraham G; Delaney, Joseph A C; Etminan, Mahyar

Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride.

Bird, Steven T; Brophy, James M; Hartzema, Abraham G; Delaney, Joseph A C; Etminan, Mahyar.

Afiliação

Bird ST; U.S. Department of Health and Human Services/U.S. Food and Drug Administration/Center for Drug Evaluation and Research/Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology/Department of Epidemiology, Silver Spring, Maryland; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida.

J Urol ; 190(5): 1811-4, 2013 Nov.

Article em En | MEDLINE | ID: mdl-23665270

Assuntos

Inibidores de 5-alfa Redutase/efeitos adversos; Azasteroides/efeitos adversos; Neoplasias da Mama Masculina/induzido quimicamente; Neoplasias da Mama Masculina/epidemiologia; Finasterida/efeitos adversos; Adulto; Idoso; Idoso de 80 Anos ou mais; Dutasterida; Humanos; Masculino; Pessoa de Meia-Idade

Palavras-chave

5-alpha reductase inhibitors; 5ARI; 5α-reductase inhibitor; FDA; Food and Drug Administration; PPV; breast neoplasms; male; positive predictive value

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azasteroides / Finasterida / Neoplasias da Mama Masculina / Inibidores de 5-alfa Redutase Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google